Blood

The Extended Diabetes Risk Test Package is designed for individuals seeking comprehensive monitoring of blood glucose levels, pancreatic, and liver function. This package helps assess the risk of developing type 2 diabetes and related metabolic disorders. It offers a detailed analysis of carbohydrate and lipid metabolism, as well as internal organ function, enabling early detection of insulin resistance and diabetes-related complications.

The CMV IgG Avidity test assesses the strength of binding of IgG antibodies to cytomegalovirus (CMV) antigens.

A blood test to aid in the diagnosis of myositis. performed to verify the presence of IgG antibodies specific to antigens: Scl-70, CENP A, CENP B, RP11, RP155, Fibrillarin, NOR-90, Th/To, PM-Scl 100, PM-Scl 75, Ku, PDGFR, Ro-52.

A blood test measuring the activity of serine protease - Protein C (PC) - is useful in diagnosing acquired and congenital Protein C deficiencies.

Complete blood count with full leukocyte differentiation (6-diff) is a test that measures the number and types of blood cells, including a detailed breakdown of white blood cells (leukocytes) into six different types. It is performed to assess overall health, diagnose infections, inflammatory conditions, immune disorders, and hematological diseases such as leukemia.

The CA 19-9 tumor marker is a protein measured in the blood, often elevated in cases of gastrointestinal cancers, especially pancreatic cancer. This marker test is performed for diagnosis, monitoring treatment, and assessing disease progression and recurrence in cancers such as pancreatic cancer or colorectal cancer.

The test provides a comprehensive view of iron metabolism. It is performed to determine transferrin saturation with iron (TSAT), a percentage indicator that represents the ratio of iron concentration to transferrin concentration or the ratio of iron to total iron-binding capacity.